Patents Assigned to LipoSciences, LLC
  • Patent number: 10022454
    Abstract: Disclosed herein are compositions and methods for generating ribo-nucleic neutral (RNN) or deoxyribo-nucleic-neutral (DNN) polynucleotides with reduced anionic charge, for improved intracellular delivery. Also disclosed herein are methods of using RNN and DNN compositions.
    Type: Grant
    Filed: February 17, 2014
    Date of Patent: July 17, 2018
    Assignee: LipoSciences, LLC
    Inventor: Scott G. Petersen